Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

SeNostic

SeNostic
2014 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Seed LATEST DEAL TYPE
2 INVESTORS
Description

Developer of novel technologies designed to provide diagnosis for diseases of the central nervous system. The company's SeedCycler Technology platform is used for the precise and accurate early differential diagnosis of neurodegenerative disorders, including Alzheimer's disease or Parkinson's disease, enabling patients to begin treatment more quickly and result in a higher likelihood of a successful treatment.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • Feodor-Lynen-Straße 21
  • 30625 Hannover
  • Germany

+49 0511 00000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore SeNostic’s full profile, request a free trial.

SeNostic Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 25-Jan-2016 Completed Startup
1. Seed Round Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

SeNostic Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
High-Tech Gründerfonds Venture Capital Minority 000 0000 000000 0
MBG Mittelständische Beteiligungsgesellschaft Baden-Württemberg Venture Capital Minority 000 0000 000000 0

SeNostic Executive Team (4)

Name Title Board
Seat
Contact
Info
Thorsten Lührs Ph.D Co-Founder, Chief Executive Officer & Managing Director
Christiane Ritter Ph.D Co-Founder, Chief Scientific Officer and Managing Scientific Director
Karl-Josef Eberle Chief Quality Manager and Project Engineer
Klaus Nathusius Ph.D Advisor